| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
MEMO TO THE MEDIA |
Press Release
BRCA2 Carriers At Increased Risk for Deadly Form of Prostate Cancer
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
| The first 10% of the full text of this article appears below. |
Carriers of a BRCA2 variation specific to Iceland are more likely to develop aggressive and lethal prostate cancer than noncarriers, according to a study published online June 12 in the Journal of the National Cancer Institute.
Mutations in the BRCA2 gene are associated with increased prostate cancer risk, but it has been unclear whether they are related to progression of
Note to Reporters:
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 929-935.
J Natl Cancer Inst 2007 99: 908-909.